Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mammography | 246 | 2023 | 2475 | 19.190 |
Why?
|
Breast Neoplasms | 268 | 2023 | 20824 | 7.860 |
Why?
|
Mass Screening | 103 | 2023 | 5253 | 5.630 |
Why?
|
Early Detection of Cancer | 34 | 2023 | 3086 | 3.820 |
Why?
|
Radiographic Image Enhancement | 24 | 2021 | 885 | 3.480 |
Why?
|
Breast | 48 | 2022 | 1970 | 2.850 |
Why?
|
Ultrasonography, Mammary | 16 | 2022 | 250 | 2.520 |
Why?
|
Carcinoma, Intraductal, Noninfiltrating | 16 | 2021 | 948 | 1.830 |
Why?
|
Breast Diseases | 25 | 2011 | 443 | 1.640 |
Why?
|
Carcinoma, Ductal, Breast | 12 | 2021 | 1100 | 1.350 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 14 | 2014 | 1184 | 1.270 |
Why?
|
Biopsy, Needle | 18 | 2008 | 1641 | 1.180 |
Why?
|
Calcinosis | 15 | 2011 | 1499 | 1.010 |
Why?
|
Female | 298 | 2023 | 380193 | 0.950 |
Why?
|
Carcinoma, Lobular | 4 | 2012 | 484 | 0.890 |
Why?
|
Carcinoma in Situ | 6 | 2021 | 806 | 0.740 |
Why?
|
Humans | 321 | 2023 | 744366 | 0.710 |
Why?
|
Health Services Misuse | 2 | 2012 | 243 | 0.700 |
Why?
|
Health Planning Guidelines | 2 | 2010 | 163 | 0.700 |
Why?
|
Canada | 14 | 2021 | 2065 | 0.690 |
Why?
|
Diagnostic Errors | 3 | 2022 | 1257 | 0.660 |
Why?
|
Randomized Controlled Trials as Topic | 24 | 2017 | 9955 | 0.560 |
Why?
|
Age Factors | 43 | 2010 | 18373 | 0.540 |
Why?
|
Diagnosis, Computer-Assisted | 6 | 2006 | 719 | 0.520 |
Why?
|
False Positive Reactions | 17 | 2013 | 980 | 0.510 |
Why?
|
Malpractice | 3 | 2004 | 572 | 0.500 |
Why?
|
Palpation | 12 | 2005 | 167 | 0.490 |
Why?
|
Needles | 8 | 2013 | 449 | 0.460 |
Why?
|
Middle Aged | 132 | 2023 | 213390 | 0.450 |
Why?
|
Research Design | 17 | 2020 | 5984 | 0.440 |
Why?
|
Selection Bias | 4 | 2017 | 371 | 0.430 |
Why?
|
Image Processing, Computer-Assisted | 10 | 2017 | 8949 | 0.410 |
Why?
|
Evidence-Based Medicine | 4 | 2018 | 3611 | 0.410 |
Why?
|
Neoplasms, Radiation-Induced | 4 | 2011 | 547 | 0.410 |
Why?
|
Sensitivity and Specificity | 19 | 2021 | 14723 | 0.400 |
Why?
|
Tomography, Optical | 5 | 2017 | 126 | 0.400 |
Why?
|
Algorithms | 11 | 2018 | 13882 | 0.390 |
Why?
|
Adult | 119 | 2020 | 214052 | 0.390 |
Why?
|
Practice Guidelines as Topic | 11 | 2020 | 7282 | 0.390 |
Why?
|
Publication Bias | 3 | 2013 | 162 | 0.390 |
Why?
|
Tomography | 3 | 2008 | 390 | 0.370 |
Why?
|
Radiology | 9 | 2009 | 2099 | 0.370 |
Why?
|
Tomography, X-Ray | 1 | 2009 | 61 | 0.360 |
Why?
|
Dissent and Disputes | 2 | 2022 | 141 | 0.340 |
Why?
|
X-Ray Film | 1 | 2008 | 33 | 0.330 |
Why?
|
Ultrasonography | 22 | 2005 | 5984 | 0.320 |
Why?
|
Preventive Medicine | 1 | 2010 | 264 | 0.320 |
Why?
|
False Negative Reactions | 8 | 2007 | 588 | 0.320 |
Why?
|
Periodicals as Topic | 4 | 2013 | 1431 | 0.310 |
Why?
|
Rectus Abdominis | 1 | 2008 | 97 | 0.310 |
Why?
|
United States | 37 | 2022 | 69872 | 0.300 |
Why?
|
Electric Impedance | 2 | 2008 | 729 | 0.300 |
Why?
|
Biopsy | 16 | 2007 | 6755 | 0.290 |
Why?
|
Biomedical Research | 1 | 2021 | 3309 | 0.270 |
Why?
|
Consensus Development Conferences, NIH as Topic | 2 | 2010 | 28 | 0.270 |
Why?
|
Communication | 6 | 2022 | 3750 | 0.260 |
Why?
|
Magnetic Resonance Imaging | 17 | 2010 | 35425 | 0.260 |
Why?
|
Subcutaneous Fat | 1 | 2008 | 391 | 0.260 |
Why?
|
Image Enhancement | 6 | 2015 | 2921 | 0.250 |
Why?
|
Age Distribution | 11 | 2012 | 2902 | 0.250 |
Why?
|
Device Approval | 2 | 2015 | 163 | 0.240 |
Why?
|
Epidemiologic Research Design | 1 | 2008 | 367 | 0.240 |
Why?
|
Survival Rate | 16 | 2013 | 12788 | 0.240 |
Why?
|
Breast Neoplasms, Male | 1 | 2005 | 210 | 0.230 |
Why?
|
Radiography, Interventional | 3 | 1999 | 1095 | 0.230 |
Why?
|
Clinical Trials as Topic | 6 | 2021 | 7914 | 0.230 |
Why?
|
Fibroadenoma | 2 | 2004 | 43 | 0.230 |
Why?
|
Mammaplasty | 2 | 2008 | 1204 | 0.210 |
Why?
|
Predictive Value of Tests | 14 | 2017 | 15078 | 0.210 |
Why?
|
Hamartoma | 1 | 2004 | 238 | 0.210 |
Why?
|
Preoperative Care | 6 | 2022 | 2251 | 0.210 |
Why?
|
Imaging, Three-Dimensional | 6 | 2015 | 4042 | 0.210 |
Why?
|
Terminology as Topic | 5 | 1997 | 1547 | 0.210 |
Why?
|
Echo-Planar Imaging | 5 | 2005 | 659 | 0.200 |
Why?
|
Women's Health | 2 | 2012 | 2034 | 0.200 |
Why?
|
Advisory Committees | 3 | 2010 | 775 | 0.200 |
Why?
|
Tomography, X-Ray Computed | 10 | 2013 | 20130 | 0.200 |
Why?
|
Clinical Competence | 3 | 2009 | 4687 | 0.200 |
Why?
|
Societies, Medical | 4 | 2005 | 3743 | 0.200 |
Why?
|
Surgical Instruments | 2 | 2001 | 395 | 0.190 |
Why?
|
Information Services | 1 | 2002 | 244 | 0.190 |
Why?
|
Carcinoma | 9 | 2003 | 2375 | 0.190 |
Why?
|
Reproducibility of Results | 12 | 2017 | 19905 | 0.190 |
Why?
|
Lactation | 1 | 2003 | 412 | 0.190 |
Why?
|
Cysts | 3 | 2001 | 678 | 0.190 |
Why?
|
Hemangioma | 1 | 2005 | 738 | 0.190 |
Why?
|
Aged | 57 | 2018 | 163288 | 0.180 |
Why?
|
Health Services Accessibility | 1 | 2017 | 5135 | 0.180 |
Why?
|
Prostheses and Implants | 4 | 1994 | 1387 | 0.180 |
Why?
|
Genes, BRCA1 | 6 | 2010 | 781 | 0.170 |
Why?
|
Risk Assessment | 9 | 2011 | 23336 | 0.170 |
Why?
|
Surgical Flaps | 1 | 2008 | 1640 | 0.170 |
Why?
|
Subtraction Technique | 2 | 2015 | 525 | 0.170 |
Why?
|
Models, Biological | 2 | 2008 | 9584 | 0.170 |
Why?
|
Medical Records | 2 | 1997 | 1413 | 0.170 |
Why?
|
Diagnosis, Differential | 17 | 2005 | 12961 | 0.160 |
Why?
|
Information Storage and Retrieval | 1 | 2004 | 824 | 0.160 |
Why?
|
Neoplasm Recurrence, Local | 6 | 2008 | 9240 | 0.160 |
Why?
|
Breast Implants | 3 | 1997 | 387 | 0.160 |
Why?
|
United States Food and Drug Administration | 2 | 2015 | 1584 | 0.160 |
Why?
|
Hemoglobins | 5 | 2009 | 1532 | 0.160 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2002 | 604 | 0.160 |
Why?
|
Forecasting | 2 | 2021 | 2951 | 0.150 |
Why?
|
Insurance, Health | 1 | 2010 | 2494 | 0.150 |
Why?
|
Science | 2 | 2010 | 241 | 0.150 |
Why?
|
Gadolinium | 1 | 2003 | 952 | 0.150 |
Why?
|
Neoplasm Invasiveness | 6 | 2015 | 3616 | 0.150 |
Why?
|
Registries | 6 | 2023 | 8091 | 0.150 |
Why?
|
Silicones | 2 | 1996 | 250 | 0.140 |
Why?
|
Mastectomy | 5 | 2023 | 1793 | 0.140 |
Why?
|
Optics and Photonics | 3 | 2017 | 321 | 0.140 |
Why?
|
Cost-Benefit Analysis | 5 | 2017 | 5388 | 0.130 |
Why?
|
Radiation Dosage | 3 | 2015 | 1928 | 0.130 |
Why?
|
Computer Simulation | 4 | 2008 | 6194 | 0.130 |
Why?
|
Physical Examination | 6 | 2004 | 1237 | 0.130 |
Why?
|
Observer Variation | 5 | 2007 | 2593 | 0.130 |
Why?
|
Publishing | 1 | 2003 | 833 | 0.130 |
Why?
|
Transillumination | 4 | 1987 | 21 | 0.130 |
Why?
|
Xeromammography | 7 | 1984 | 21 | 0.130 |
Why?
|
Retrospective Studies | 25 | 2023 | 77460 | 0.120 |
Why?
|
Pattern Recognition, Automated | 3 | 2015 | 1005 | 0.120 |
Why?
|
Oxygen | 6 | 2010 | 4189 | 0.120 |
Why?
|
Guidelines as Topic | 3 | 2015 | 1405 | 0.120 |
Why?
|
New England | 1 | 2016 | 1022 | 0.120 |
Why?
|
Menopause | 8 | 2005 | 1626 | 0.110 |
Why?
|
Sweden | 2 | 2011 | 1341 | 0.110 |
Why?
|
Silicone Elastomers | 1 | 1993 | 84 | 0.110 |
Why?
|
Survival Analysis | 8 | 2011 | 10252 | 0.110 |
Why?
|
Physicians, Family | 1 | 1995 | 345 | 0.110 |
Why?
|
Health Education | 1 | 1999 | 1056 | 0.110 |
Why?
|
Time Factors | 12 | 2017 | 40075 | 0.110 |
Why?
|
Fiducial Markers | 1 | 2013 | 136 | 0.100 |
Why?
|
Anxiety | 2 | 2004 | 4293 | 0.100 |
Why?
|
Follow-Up Studies | 15 | 2013 | 39052 | 0.100 |
Why?
|
Physicians | 2 | 2003 | 4567 | 0.100 |
Why?
|
Cause of Death | 1 | 2002 | 3582 | 0.100 |
Why?
|
Databases, Factual | 2 | 2023 | 7730 | 0.100 |
Why?
|
History, 21st Century | 1 | 2017 | 1534 | 0.100 |
Why?
|
Decision Making | 1 | 2005 | 3888 | 0.100 |
Why?
|
Radiography, Thoracic | 2 | 1996 | 1265 | 0.100 |
Why?
|
Genes, BRCA2 | 4 | 2009 | 618 | 0.100 |
Why?
|
Radiation, Ionizing | 1 | 2011 | 258 | 0.090 |
Why?
|
Risk | 6 | 2017 | 9688 | 0.090 |
Why?
|
Breast Self-Examination | 1 | 2010 | 34 | 0.090 |
Why?
|
Artificial Intelligence | 4 | 2010 | 2213 | 0.090 |
Why?
|
Magnetic Resonance Spectroscopy | 6 | 1996 | 3759 | 0.090 |
Why?
|
Incidence | 9 | 2009 | 20952 | 0.090 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2015 | 3326 | 0.090 |
Why?
|
Statistics as Topic | 4 | 2002 | 2373 | 0.090 |
Why?
|
Sutures | 1 | 1992 | 299 | 0.090 |
Why?
|
History, 20th Century | 1 | 2017 | 2740 | 0.090 |
Why?
|
Prognosis | 9 | 2017 | 29060 | 0.090 |
Why?
|
Phantoms, Imaging | 5 | 2017 | 2480 | 0.080 |
Why?
|
Neoplasms, Unknown Primary | 1 | 2010 | 104 | 0.080 |
Why?
|
Neoplasm Seeding | 1 | 1988 | 87 | 0.080 |
Why?
|
Nuclear Physics | 1 | 2008 | 79 | 0.080 |
Why?
|
Spectrophotometry, Infrared | 2 | 2006 | 114 | 0.080 |
Why?
|
Equipment Design | 5 | 2013 | 3582 | 0.070 |
Why?
|
Commerce | 1 | 2012 | 592 | 0.070 |
Why?
|
Peer Review, Research | 2 | 2003 | 329 | 0.070 |
Why?
|
Netherlands | 1 | 2011 | 2170 | 0.070 |
Why?
|
Gene Expression Profiling | 1 | 2003 | 9445 | 0.070 |
Why?
|
Patient Satisfaction | 2 | 1997 | 3395 | 0.070 |
Why?
|
Phyllodes Tumor | 2 | 1983 | 53 | 0.070 |
Why?
|
ROC Curve | 6 | 2010 | 3528 | 0.070 |
Why?
|
Policy Making | 1 | 2010 | 554 | 0.070 |
Why?
|
Monte Carlo Method | 2 | 2010 | 1254 | 0.070 |
Why?
|
Ultrasonography, Interventional | 1 | 1994 | 1486 | 0.070 |
Why?
|
Gadolinium DTPA | 3 | 2005 | 836 | 0.070 |
Why?
|
Relative Biological Effectiveness | 1 | 2008 | 323 | 0.070 |
Why?
|
Massachusetts | 6 | 2007 | 8662 | 0.070 |
Why?
|
Self Disclosure | 1 | 2007 | 251 | 0.070 |
Why?
|
Hyperplasia | 2 | 2008 | 1185 | 0.070 |
Why?
|
Medical History Taking | 2 | 2007 | 784 | 0.070 |
Why?
|
Medical Records Systems, Computerized | 1 | 1992 | 1205 | 0.070 |
Why?
|
Health Policy | 3 | 2010 | 2661 | 0.070 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1998 | 2020 | 0.070 |
Why?
|
Tamoxifen | 3 | 2005 | 981 | 0.070 |
Why?
|
Diagnostic Imaging | 3 | 2008 | 3508 | 0.070 |
Why?
|
Patient Preference | 1 | 2012 | 889 | 0.060 |
Why?
|
Preventive Health Services | 1 | 2010 | 575 | 0.060 |
Why?
|
Methods | 4 | 1992 | 1129 | 0.060 |
Why?
|
Risk Management | 1 | 2009 | 571 | 0.060 |
Why?
|
Mathematics | 2 | 2003 | 728 | 0.060 |
Why?
|
Physical Stimulation | 1 | 2006 | 525 | 0.060 |
Why?
|
Skin | 4 | 2008 | 4372 | 0.060 |
Why?
|
Data Interpretation, Statistical | 3 | 2003 | 2716 | 0.060 |
Why?
|
Markov Chains | 1 | 2008 | 969 | 0.060 |
Why?
|
Insurance, Liability | 1 | 2004 | 102 | 0.060 |
Why?
|
Weight-Bearing | 1 | 2006 | 515 | 0.060 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2008 | 450 | 0.060 |
Why?
|
Combined Modality Therapy | 5 | 2013 | 8642 | 0.060 |
Why?
|
Politics | 1 | 2010 | 791 | 0.060 |
Why?
|
Controlled Clinical Trials as Topic | 1 | 2004 | 187 | 0.060 |
Why?
|
Premenopause | 2 | 2004 | 1033 | 0.060 |
Why?
|
Quality-Adjusted Life Years | 1 | 2010 | 1683 | 0.060 |
Why?
|
Selective Estrogen Receptor Modulators | 1 | 2004 | 129 | 0.060 |
Why?
|
Adenofibroma | 1 | 1982 | 25 | 0.060 |
Why?
|
Aged, 80 and over | 13 | 2013 | 57776 | 0.060 |
Why?
|
Interprofessional Relations | 1 | 1989 | 1011 | 0.060 |
Why?
|
Menstrual Cycle | 2 | 2005 | 551 | 0.050 |
Why?
|
Treatment Outcome | 3 | 2021 | 63107 | 0.050 |
Why?
|
Linear Models | 3 | 2008 | 5953 | 0.050 |
Why?
|
Blood Flow Velocity | 1 | 2006 | 1423 | 0.050 |
Why?
|
Neoplasm Metastasis | 3 | 2003 | 4851 | 0.050 |
Why?
|
Estrogen Replacement Therapy | 2 | 2009 | 1203 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 1996 | 3841 | 0.050 |
Why?
|
Radionuclide Imaging | 2 | 2006 | 2031 | 0.050 |
Why?
|
Neoplasm Staging | 5 | 2013 | 11031 | 0.050 |
Why?
|
Patient Dropouts | 2 | 1994 | 420 | 0.050 |
Why?
|
Risk Factors | 12 | 2012 | 72296 | 0.050 |
Why?
|
Ovary | 1 | 1986 | 981 | 0.050 |
Why?
|
Health Care Reform | 1 | 2010 | 1261 | 0.050 |
Why?
|
Quality Control | 2 | 1993 | 841 | 0.050 |
Why?
|
Biopsy, Fine-Needle | 1 | 2005 | 1094 | 0.050 |
Why?
|
Progesterone | 1 | 2005 | 775 | 0.050 |
Why?
|
Muscle, Skeletal | 1 | 1996 | 4925 | 0.050 |
Why?
|
Lipoma | 1 | 1982 | 334 | 0.050 |
Why?
|
Neoplasms | 2 | 2007 | 21696 | 0.040 |
Why?
|
Ethics, Medical | 1 | 2004 | 792 | 0.040 |
Why?
|
Quality Assurance, Health Care | 2 | 2005 | 2212 | 0.040 |
Why?
|
Public Opinion | 1 | 2003 | 477 | 0.040 |
Why?
|
Hospitals, General | 2 | 1993 | 749 | 0.040 |
Why?
|
Program Development | 1 | 2005 | 1316 | 0.040 |
Why?
|
Emotions | 1 | 2010 | 2659 | 0.040 |
Why?
|
Dermatitis | 1 | 1980 | 199 | 0.040 |
Why?
|
Early Diagnosis | 1 | 2003 | 1184 | 0.040 |
Why?
|
Attitude to Health | 2 | 2004 | 2052 | 0.040 |
Why?
|
Genetic Testing | 2 | 2008 | 3444 | 0.040 |
Why?
|
Probability | 2 | 2004 | 2506 | 0.040 |
Why?
|
Angioplasty, Balloon | 1 | 1982 | 653 | 0.040 |
Why?
|
Decision Support Techniques | 1 | 2008 | 1956 | 0.040 |
Why?
|
Discriminant Analysis | 2 | 2010 | 235 | 0.040 |
Why?
|
Chemotherapy, Adjuvant | 5 | 2005 | 3480 | 0.040 |
Why?
|
Data Collection | 1 | 2007 | 3339 | 0.040 |
Why?
|
Adolescent | 7 | 2011 | 85779 | 0.040 |
Why?
|
Artifacts | 1 | 2006 | 1904 | 0.040 |
Why?
|
Consensus Development Conferences as Topic | 1 | 1998 | 170 | 0.040 |
Why?
|
Receptors, Estrogen | 1 | 2005 | 2190 | 0.040 |
Why?
|
Posture | 1 | 2001 | 958 | 0.040 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2004 | 1534 | 0.040 |
Why?
|
Equipment Failure Analysis | 2 | 2013 | 868 | 0.040 |
Why?
|
Program Evaluation | 1 | 2005 | 2488 | 0.040 |
Why?
|
Normal Distribution | 1 | 2017 | 280 | 0.030 |
Why?
|
Contrast Media | 3 | 2005 | 5300 | 0.030 |
Why?
|
Lymph Nodes | 3 | 1986 | 3476 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 3 | 2008 | 17446 | 0.030 |
Why?
|
Radio Waves | 1 | 2017 | 251 | 0.030 |
Why?
|
Cell Division | 1 | 2003 | 4569 | 0.030 |
Why?
|
Appointments and Schedules | 1 | 1999 | 417 | 0.030 |
Why?
|
Skin Diseases | 1 | 1983 | 1066 | 0.030 |
Why?
|
Sternum | 1 | 1996 | 177 | 0.030 |
Why?
|
Ovarian Neoplasms | 3 | 2007 | 4839 | 0.030 |
Why?
|
British Columbia | 1 | 1995 | 244 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2000 | 1680 | 0.030 |
Why?
|
Diagnostic Tests, Routine | 2 | 1998 | 783 | 0.030 |
Why?
|
Information Dissemination | 1 | 2003 | 1099 | 0.030 |
Why?
|
Models, Theoretical | 3 | 2003 | 3589 | 0.030 |
Why?
|
Papilloma, Intraductal | 1 | 1994 | 22 | 0.030 |
Why?
|
Thermography | 2 | 1984 | 67 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2004 | 6896 | 0.030 |
Why?
|
Rectal Neoplasms | 1 | 1983 | 1205 | 0.030 |
Why?
|
Fibrocystic Breast Disease | 1 | 1994 | 102 | 0.030 |
Why?
|
Double-Blind Method | 1 | 2007 | 12025 | 0.030 |
Why?
|
Sampling Studies | 1 | 1994 | 623 | 0.030 |
Why?
|
Cost Control | 1 | 1995 | 624 | 0.030 |
Why?
|
Random Allocation | 1 | 1997 | 2428 | 0.030 |
Why?
|
Actuarial Analysis | 1 | 1992 | 378 | 0.030 |
Why?
|
Stress, Mechanical | 2 | 2008 | 1686 | 0.030 |
Why?
|
Life Expectancy | 2 | 2010 | 1184 | 0.030 |
Why?
|
Cytodiagnosis | 2 | 1989 | 435 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2005 | 21748 | 0.030 |
Why?
|
Pilot Projects | 4 | 2008 | 8319 | 0.030 |
Why?
|
Stereotaxic Techniques | 1 | 1993 | 536 | 0.020 |
Why?
|
Young Adult | 3 | 2013 | 56429 | 0.020 |
Why?
|
National Institutes of Health (U.S.) | 1 | 1995 | 780 | 0.020 |
Why?
|
Models, Statistical | 1 | 2006 | 5101 | 0.020 |
Why?
|
Feasibility Studies | 2 | 2015 | 5077 | 0.020 |
Why?
|
Analysis of Variance | 3 | 2005 | 6366 | 0.020 |
Why?
|
Radiography | 5 | 1992 | 7023 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 1983 | 2542 | 0.020 |
Why?
|
Educational Status | 2 | 2012 | 2540 | 0.020 |
Why?
|
Sentinel Lymph Node Biopsy | 2 | 2005 | 710 | 0.020 |
Why?
|
Epidemiologic Methods | 2 | 1993 | 1364 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2005 | 3922 | 0.020 |
Why?
|
Mortality | 2 | 2017 | 2864 | 0.020 |
Why?
|
Prospective Studies | 6 | 2005 | 53290 | 0.020 |
Why?
|
Liver | 2 | 1996 | 7475 | 0.020 |
Why?
|
Computers | 2 | 1984 | 612 | 0.020 |
Why?
|
Adenocarcinoma | 2 | 1987 | 6364 | 0.020 |
Why?
|
X-Ray Intensifying Screens | 1 | 1988 | 32 | 0.020 |
Why?
|
Quality of Life | 1 | 2010 | 12802 | 0.020 |
Why?
|
Pressure | 2 | 2009 | 1203 | 0.020 |
Why?
|
Lymphoma | 3 | 1989 | 1877 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 1993 | 1342 | 0.020 |
Why?
|
Calcium | 1 | 2001 | 5755 | 0.020 |
Why?
|
Pelvis | 2 | 1982 | 730 | 0.020 |
Why?
|
Neovascularization, Pathologic | 1 | 1997 | 2638 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 1994 | 2879 | 0.020 |
Why?
|
Microcomputers | 1 | 2007 | 147 | 0.020 |
Why?
|
Finite Element Analysis | 1 | 2009 | 431 | 0.020 |
Why?
|
Prevalence | 2 | 2012 | 15221 | 0.020 |
Why?
|
Genes, p53 | 1 | 2009 | 755 | 0.020 |
Why?
|
Compressive Strength | 1 | 2006 | 169 | 0.020 |
Why?
|
Oximetry | 1 | 2008 | 471 | 0.020 |
Why?
|
Socioeconomic Factors | 2 | 2012 | 7785 | 0.020 |
Why?
|
Genetic Counseling | 1 | 2009 | 600 | 0.020 |
Why?
|
Oils | 1 | 1985 | 63 | 0.020 |
Why?
|
Body Fluids | 1 | 1986 | 319 | 0.020 |
Why?
|
Radiotherapy | 1 | 1992 | 1533 | 0.020 |
Why?
|
Caseins | 1 | 1985 | 104 | 0.020 |
Why?
|
Scattering, Radiation | 1 | 2006 | 498 | 0.020 |
Why?
|
Patient Selection | 1 | 1997 | 4216 | 0.020 |
Why?
|
Plant Oils | 1 | 1985 | 202 | 0.010 |
Why?
|
Endometrium | 1 | 1986 | 424 | 0.010 |
Why?
|
Mutation | 4 | 2010 | 29786 | 0.010 |
Why?
|
Population Surveillance | 1 | 1994 | 2616 | 0.010 |
Why?
|
Bile Ducts | 1 | 1985 | 284 | 0.010 |
Why?
|
Suction | 1 | 1984 | 267 | 0.010 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2008 | 721 | 0.010 |
Why?
|
Carcinoma, Ductal | 1 | 2003 | 101 | 0.010 |
Why?
|
PTEN Phosphohydrolase | 1 | 2009 | 1142 | 0.010 |
Why?
|
SEER Program | 1 | 2008 | 1507 | 0.010 |
Why?
|
Cultural Characteristics | 1 | 2004 | 262 | 0.010 |
Why?
|
Carbohydrates | 1 | 1985 | 394 | 0.010 |
Why?
|
Common Bile Duct Diseases | 1 | 1982 | 37 | 0.010 |
Why?
|
Technetium | 1 | 1983 | 334 | 0.010 |
Why?
|
Wound Healing | 1 | 1994 | 2785 | 0.010 |
Why?
|
Photons | 1 | 2006 | 588 | 0.010 |
Why?
|
Methylene Blue | 1 | 1983 | 155 | 0.010 |
Why?
|
Lymphatic Metastasis | 2 | 1987 | 2924 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2005 | 13693 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 2008 | 1868 | 0.010 |
Why?
|
Aromatase Inhibitors | 1 | 2005 | 490 | 0.010 |
Why?
|
Carcinoma, Papillary | 1 | 1987 | 783 | 0.010 |
Why?
|
Logistic Models | 1 | 1996 | 13409 | 0.010 |
Why?
|
Europe | 1 | 1988 | 3338 | 0.010 |
Why?
|
Pregnancy | 1 | 2003 | 29144 | 0.010 |
Why?
|
Hydronephrosis | 1 | 1982 | 269 | 0.010 |
Why?
|
Adipose Tissue | 1 | 1993 | 3280 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 2 | 2004 | 3020 | 0.010 |
Why?
|
Knee | 1 | 1982 | 274 | 0.010 |
Why?
|
Blood Volume | 1 | 2002 | 565 | 0.010 |
Why?
|
Axilla | 1 | 1983 | 597 | 0.010 |
Why?
|
Nitriles | 1 | 2005 | 955 | 0.010 |
Why?
|
Mastectomy, Segmental | 1 | 2005 | 956 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2005 | 1771 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2006 | 3508 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2006 | 1312 | 0.010 |
Why?
|
Lymphadenitis | 1 | 1980 | 98 | 0.010 |
Why?
|
Triazoles | 1 | 2005 | 908 | 0.010 |
Why?
|
Boston | 1 | 2012 | 9312 | 0.010 |
Why?
|
Episode of Care | 1 | 2000 | 126 | 0.010 |
Why?
|
Hormone Replacement Therapy | 1 | 2005 | 745 | 0.010 |
Why?
|
Male | 6 | 2005 | 350115 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 2002 | 1525 | 0.010 |
Why?
|
Models, Structural | 2 | 1988 | 361 | 0.010 |
Why?
|
Reference Values | 1 | 1986 | 4982 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 1992 | 3229 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 1996 | 5321 | 0.010 |
Why?
|
Diphosphonates | 1 | 1983 | 623 | 0.010 |
Why?
|
Rectum | 1 | 1983 | 904 | 0.010 |
Why?
|
Pain Measurement | 1 | 1988 | 3420 | 0.010 |
Why?
|
Foreign Bodies | 1 | 1982 | 400 | 0.010 |
Why?
|
Uterine Neoplasms | 1 | 2007 | 1513 | 0.010 |
Why?
|
Body Mass Index | 2 | 2007 | 12721 | 0.010 |
Why?
|
Microcirculation | 1 | 2002 | 1287 | 0.010 |
Why?
|
Body Height | 1 | 1984 | 1578 | 0.010 |
Why?
|
Pedigree | 1 | 2005 | 4642 | 0.010 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2005 | 1524 | 0.010 |
Why?
|
Absorptiometry, Photon | 1 | 2003 | 1725 | 0.010 |
Why?
|
Dietary Fats | 1 | 1985 | 2016 | 0.010 |
Why?
|
Hydrogen | 1 | 1996 | 164 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2000 | 1590 | 0.010 |
Why?
|
Postmenopause | 1 | 2005 | 2460 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2003 | 1739 | 0.010 |
Why?
|
Aging | 1 | 1994 | 8664 | 0.010 |
Why?
|
Colon | 1 | 1983 | 1772 | 0.010 |
Why?
|
Thyroid Neoplasms | 1 | 1987 | 2282 | 0.010 |
Why?
|
Patient Compliance | 1 | 2003 | 2684 | 0.010 |
Why?
|
Body Weight | 1 | 1984 | 4671 | 0.010 |
Why?
|
Software | 1 | 2007 | 4441 | 0.010 |
Why?
|
Education, Medical | 1 | 2004 | 1722 | 0.010 |
Why?
|
Prosthesis Failure | 1 | 1996 | 1206 | 0.010 |
Why?
|
Bone Neoplasms | 1 | 1983 | 2530 | 0.010 |
Why?
|
Radiographic Magnification | 1 | 1988 | 20 | 0.010 |
Why?
|
Medical Audit | 1 | 1990 | 467 | 0.010 |
Why?
|
Colorectal Neoplasms | 1 | 2007 | 6773 | 0.000 |
Why?
|
Reoperation | 1 | 1996 | 4201 | 0.000 |
Why?
|
Technology, Radiologic | 1 | 1987 | 163 | 0.000 |
Why?
|
Contraceptives, Oral | 1 | 1989 | 564 | 0.000 |
Why?
|
Parity | 1 | 1989 | 929 | 0.000 |
Why?
|
Cross-Sectional Studies | 1 | 2007 | 25039 | 0.000 |
Why?
|
Cholestasis, Extrahepatic | 1 | 1985 | 51 | 0.000 |
Why?
|
Hepatic Duct, Common | 1 | 1985 | 50 | 0.000 |
Why?
|
Pelvic Neoplasms | 1 | 1986 | 254 | 0.000 |
Why?
|
Lymphatic Diseases | 1 | 1985 | 323 | 0.000 |
Why?
|
Cholelithiasis | 1 | 1985 | 414 | 0.000 |
Why?
|
Attitude | 1 | 1988 | 776 | 0.000 |
Why?
|
Cohort Studies | 1 | 2005 | 40559 | 0.000 |
Why?
|
Technetium Tc 99m Medronate | 1 | 1983 | 136 | 0.000 |
Why?
|
Gallstones | 1 | 1985 | 286 | 0.000 |
Why?
|
Estrogens | 1 | 1989 | 1566 | 0.000 |
Why?
|
Kidney Tubules, Collecting | 1 | 1982 | 178 | 0.000 |
Why?
|
Fibrosis | 1 | 1988 | 2029 | 0.000 |
Why?
|
Postoperative Complications | 1 | 1982 | 15297 | 0.000 |
Why?
|
Drug Combinations | 1 | 1985 | 1958 | 0.000 |
Why?
|
Obesity | 1 | 1989 | 12746 | 0.000 |
Why?
|